Effects of cerivastatin on lipid profiles, lipid peroxidation and platelet and endothelial activation in renal transplant recipients

Transplant Proc. 2000 Dec;32(8):2787-8. doi: 10.1016/s0041-1345(00)01886-8.
No abstract available

Publication types

  • Clinical Trial
  • Multicenter Study

MeSH terms

  • Apolipoproteins / blood
  • Cholesterol / blood
  • Cholesterol, HDL / blood
  • Cholesterol, LDL / blood
  • Cyclosporine / therapeutic use
  • Drug Therapy, Combination
  • Female
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
  • Hypercholesterolemia / drug therapy*
  • Immunosuppressive Agents / therapeutic use
  • Kidney Transplantation / physiology*
  • Lipids / blood*
  • Male
  • Middle Aged
  • Postoperative Complications*
  • Pyridines / therapeutic use*
  • Triglycerides / blood

Substances

  • Apolipoproteins
  • Cholesterol, HDL
  • Cholesterol, LDL
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Immunosuppressive Agents
  • Lipids
  • Pyridines
  • Triglycerides
  • Cyclosporine
  • Cholesterol
  • cerivastatin